You may also like
FDA Issues Public Health Advisory for Trasylol
The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks and strokes in patients who undergo artery bypass graft surgery.
Evidence Maps: a Tool to Guide Research Agenda Setting
In this article, we explain how evidence maps serve a goal and outline the steps required to build effective evidence maps.
Effect of Pericardial Blood Processing on Postoperative Inflammation and the Complement Pathways
The objective of the present study was to determine the effect of processing of pericardial blood with a cell-saving device (CS) and vacuum-assisted cardiopulmonary bypass (VACPB) on reduction of postoperative inflammation.